Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Suspended × Specimen Handling × Clear all

Phase

Phase 1 14 Phase 2 7 Phase NA 2 Phase 2/3 2 Phase 4 1 Phase 3 1 Phase 1/2 1

Status

Recruiting 3 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

icotinib 1 abarelix 1 Watchful Waiting 1 Testosterone Propionate 1 Testosterone 1 Specimen Handling 1 Prednisone 1 Oxycodone 1 Observation 1 Morphine 1 Magnetic Resonance Spectroscopy 1 Fentanyl 1 Erlotinib Hydrochloride 1 Clinical Protocols 1 Buprenorphine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06733350 2026-02-09

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Roswell Park Cancer Institute

Phase 4 Suspended

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡